- Home
- ARWR vs ADUS Comparison
ARWR vs ADUS Comparison
Compare ARWR & ADUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARWR
- ADUS
- Stock Information
- Founded
- ARWR 2003
- ADUS 1979
- Country
- ARWR United States
- ADUS United States
- Employees
- ARWR N/A
- ADUS N/A
- Industry
- ARWR Biotechnology: Pharmaceutical Preparations
- ADUS Medical/Nursing Services
- Sector
- ARWR Health Care
- ADUS Health Care
- Exchange
- ARWR Nasdaq
- ADUS Nasdaq
- Market Cap
- ARWR 2.6B
- ADUS 2.2B
- IPO Year
- ARWR 1993
- ADUS 2009
- Fundamental
- Price
- ARWR $19.90
- ADUS $109.23
- Analyst Decision
- ARWR Buy
- ADUS Buy
- Analyst Count
- ARWR 11
- ADUS 10
- Target Price
- ARWR $43.33
- ADUS $135.30
- AVG Volume (30 Days)
- ARWR 2.5M
- ADUS 170.9K
- Earning Date
- ARWR 02-10-2025
- ADUS 02-24-2025
- Dividend Yield
- ARWR N/A
- ADUS N/A
- EPS Growth
- ARWR N/A
- ADUS 23.71
- EPS
- ARWR N/A
- ADUS 4.37
- Revenue
- ARWR $2,500,000.00
- ADUS $1,133,806,000.00
- Revenue This Year
- ARWR $3,336.78
- ADUS $10.71
- Revenue Next Year
- ARWR $124.29
- ADUS $24.57
- P/E Ratio
- ARWR N/A
- ADUS $24.85
- Revenue Growth
- ARWR N/A
- ADUS 10.15
- 52 Week Low
- ARWR $17.05
- ADUS $85.94
- 52 Week High
- ARWR $36.72
- ADUS $136.72
- Technical
- Relative Strength Index (RSI)
- ARWR 49.40
- ADUS 25.48
- Support Level
- ARWR $17.57
- ADUS $112.91
- Resistance Level
- ARWR $21.84
- ADUS $117.07
- Average True Range (ATR)
- ARWR 1.06
- ADUS 2.86
- MACD
- ARWR 0.11
- ADUS -0.98
- Stochastic Oscillator
- ARWR 54.57
- ADUS 5.95
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.
About ADUS Addus HomeCare Corporation
Addus HomeCare Corp is engaged in the provision of in-home personal care services. It operates through the segments such as Personal care segment, which is a key revenue driver, provides non-medical assistance with activities of daily living, primarily to persons who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill and disabled. The Hospice segment provides physical, emotional and spiritual care for people who are terminally ill and their families. Its Home health segment provides services that are primarily medical in nature to those individuals who may require assistance during an illness or after surgery.